Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors 1Breast Neoplasms 1

Interventions

Specimen Handling 613pembrolizumab 563Magnetic Resonance Spectroscopy 536Carboplatin 425Cisplatin 375Cyclophosphamide 373Biopsy 357Paclitaxel 306Gemcitabine 303Nivolumab 300Radiotherapy 260Bevacizumab 234Dexamethasone 209fludarabine 205Docetaxel 187durvalumab 182atezolizumab 173Oxaliplatin 172venetoclax 168Fluorouracil 166Rituximab 165Pemetrexed 163Capecitabine 158Doxorubicin 157Radiation 155Radiosurgery 148Etoposide 137Leucovorin 133Ipilimumab 133Lenalidomide 131

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × hetrombopag × 90 days × Clear all
NCT05394285 2026-04-06

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

Henan Cancer Hospital

Phase 2 Completed
60 enrolled
Breast

Breast Neoplasms

NCT07492693 2026-03-25

Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors

Changhai Hospital

Phase 2 Recruiting
40 enrolled
Classical hematologyGastrointestinal

Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡